Filing Details

Accession Number:
0001628280-24-033205
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-07-26 21:45:51
Reporting Period:
2024-07-24
Accepted Time:
2024-07-26 21:45:51
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1933414 Mineralys Therapeutics Inc. MLYS () E9
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1746274 Catalys Pacific Fund, Lp Po Box 309, Ugland House, Cayman Islands
Grand Cayman E9 KY1-1104
No No Yes No
1963901 Taylor Brian Slingsby Shoto City House 203, 1-23-3, Shoto,
Shibuya-Ku Tokyo M0 150-0046
Yes No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2024-07-24 550,000 $13.05 8,644,579 No 4 S Indirect See Footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect See Footnote
Footnotes
  1. Represents securities held directly by Catalys Pacific Fund, LP. The general partner of Catalys Pacific Fund, LP is Catalys Pacific Fund GP, LP. Brian Taylor Slingsby is the managing partner of Catalys Pacific, LLC, the general partner of the General Partner. Catalys Pacific, LLC, Catalys Pacific Fund GP, LP and Brian Taylor Slingsby may be deemed to have voting and investment power over the shares held of record by Catalys Pacific Fund, LP. Each of Catalys Pacific, LLC, Catalys Pacific Fund GP, LP and Brian Taylor Slingsby disclaim beneficial ownership of such shares, except to the extent of any pecuniary interest therein.